NICE
Doubts about funding for ‘Innovation Pass’
August 10, 2009Research and Development, Sales and Marketing ABPI, NHS, NICE
The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
Kennedy and Drayson: parallel plans to boost UK’s innovation agenda
August 5, 2009Research and Development NICE, healthcare
1: The Office of Life Science’s ‘Blueprint’The first to be launched was the ‘Blueprint’ – a new strategic vision aiming …
Kennedy calls for overhaul of NICE processes
July 23, 2009Research and Development, Sales and Marketing NICE, hta
NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
NICE approves MabThera for leukaemia
July 22, 2009Research and Development, Sales and Marketing MabThera, NICE
NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
NICE bypassed in radical innovation boost
July 16, 2009Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta
Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
NICE to reconsider GSK’s Tyverb
July 9, 2009Research and Development, Sales and Marketing GSK, NICE, Tyverb
NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …
NICE takes on quality and outcomes
June 19, 2009GP, NICE, healthcare, qof, quality
Some developments at NICE, now celebrating its 10th birthday, may have passed you by. They have moved beyond their technology …
NICE defies pressure and keeps restrictions on Alzheimer’s
June 15, 2009Research and Development Alzheimer's, NICE
Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …
NICE and MRC to research watchdog’s methodology
June 5, 2009NICE
Funding worth £2 million has been made available for research into how NICE can better do its job. The drug …
NICE approves Erbitux for colon cancer
June 1, 2009Research and Development, Sales and Marketing Erbitux, NICE
NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …
Kennedy sets out views on NICE’s future
May 14, 2009Research and Development NICE
Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
NICE rejects Nexavar for liver cancer
May 7, 2009Research and Development, Sales and Marketing Bayer, NICE, Nexavar
NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
NHS should be ‘jewel in the crown’ for UK biotech
May 7, 2009Research and Development NICE
The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
